Develops intranasal powder products for various diseases.
Dec 2025Revenue $1.24B/yrExpenses $1.24B/yr
No trendCash runway ≈ 3 months from Dec 2025
Figures by year
When will Nasus Pharma be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $1.24B and expenses $1.24B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $1.24B | $1.24B | −$4.90M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.